The global cognitive and memory enhancer drugs market is expected to grow at a CAGR of 5.5 percent during the forecast period. Cognitive and memory enhancer drugs are supplements or medications that promote cognitive functional improvement. These are primarily used to treat patients with schizophrenia, stroke, Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), or geriatric patients. The major factors driving the growth of the cognitive and memory enhancer drug market include an increase in the geriatric population and an increase in the prevalence of memory-related disorders and neurological disorders.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cognitive-and-memory-enhancer-drugs-market
According to the WHO, more than 46 million people are living with dementia, which is a significant factor influencing the growth of this market. Furthermore, ongoing clinical trials and potential drugs approvals by the US FDA are some of the other factors bolstering the market’s growth. For instance, in July 2021, the US FDA approved the drug, aducanumab, first new medication for Alzheimer’s disease in the brand name Aduhelm. The drug is a monthly intravenous infusion intended to slow cognitive decline in people with mild memory and thinking problems. It is the first approved treatment to attack the disease process of Alzheimer’s instead of just addressing dementia symptoms.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product
- By ???l???t??n
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cognitive and Memory Enhancer Drugs Market by Segment
By Product
- Aricept
- Exelon
- Namenda
- Razadyne
- Provigil
- Ritalin
- Adderall and Others
By Application
- Disease Treatment Education
- Sports and Others
A full report of Cognitive and Memory Enhancer Drugs Market is available at: https://www.omrglobal.com/industry-reports/cognitive-and-memory-enhancer-drugs-market
Cognitive and Memory Enhancer Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Novartis International AG
- AbbVie
- Eisai Co., Ltd.
- Cephalon, Inc.
- AlternaScript LLC
- Allergan Plc.
- Takeda Pharmaceutical Company
- Torrent Pharmaceuticals
- Alterna Script LLC
- Reckitt Benckiser Group PLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
